Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
archives
»
Monthly Archive
» October 2011
October 2011
Glaxo Third-Quarter Earnings Match Estimates
Glaxo Third-Quarter Earnings Match Estimates
Bloomberg
earnings
GSK
Biogen readies its app after BG-12 beats Copaxone in PhIII MS study
Biogen readies its app after BG-12 beats Copaxone in PhIII MS study
Fierce Biotech
Teva Pharmaceuticals
multiple sclerosis
MS
Copaxone
Biogen
BG-12
Amgen Is Poised For Continued Success
Amgen Is Poised For Continued Success
Seeking Alpha
Amgen
Pharmasset
Dendreon
Evaluating Abbott Labs: Just How Do You Formulate Cash Flow?
Evaluating Abbott Labs: Just How Do You Formulate Cash Flow?
Seeking Alpha
Abbott Laboratories
cash
Abbott Labs: Genes Aren't The Only Thing That Can Effectively Be Spliced
Abbott Labs: Genes Aren't The Only Thing That Can Effectively Be Spliced
Seeking Alpha
Abbott Laboratories
Bardoxolone
daclizumab
Human Genome Bungles Benlysta
Human Genome Bungles Benlysta
TheStreet.com
Human Genome Sciences
Benlysta
lupus
FTC pay-for-delay study flawed?
FTC pay-for-delay study flawed?
Patent Baristas
FTC
pay-for-delay
antitrust
FDA approves Lundbeck's Onfi for LGS
FDA approves Lundbeck's Onfi for LGS
Pharma Times
Lundbeck
LGS
FDA
Onfi
epilepsy
Pradaxa May Not Stop A Different Type Of Bleeding
Pradaxa May Not Stop A Different Type Of Bleeding
Pharmalot
Boehringer Ingelheim
Pradaxa
Highflying Questcor Expected To Report 71% Sales Jump
Highflying Questcor Expected To Report 71% Sales Jump
Investors.com
earnings
Questcor
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
…
next ›
last »